Rare diseases
Investigational molecules
Locations
Back to Spain1 637 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Bepranemab for Patients with Early Alzheimer's Disease
SpainStudy Comparing Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
SpainStudy on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes
SpainSpainStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
SpainStudy on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
SpainStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
SpainStudy on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia
SpainStudy on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction
SpainStudy on IO102-IO103 and Pembrolizumab for Patients with Metastatic Lung, Head and Neck, or Bladder Cancer
SpainStudy of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease
SpainStudy on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.
Studies aim to improve treatment outcomes for patients with complex metabolic conditions.
Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.
Research focuses on developing targeted treatments for various neurological conditions.
Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.
Studies aim to enhance vaccine efficacy and immune response across different age groups.
Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.
Focus on developing innovative approaches to improve cancer treatment outcomes.
Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.
Research aims to develop more effective treatments for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
